KALA BIO, INC. Liabilities, Noncurrent
KALA BIO, INC. (KALA) had Liabilities, Noncurrent of $1.11 million as of 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LiabilitiesNoncurrent · last filed 2026-04-15
- 2025-09-30: Liabilities, Noncurrent $1.11M.
- 2025-06-30: Liabilities, Noncurrent $23.24M.
- 2025-03-31: Liabilities, Noncurrent $19.57M.
- 2024-12-31: Liabilities, Noncurrent $26.20M.
| Period end | Liabilities, Noncurrent | Liabilities, Noncurrent as first filed |
|---|---|---|
| 2025-09-30 | $1.11M 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $23.24M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $19.57M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $26.20M 10-K · filed 2026-04-15 | |
| 2024-09-30 | $23.35M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $28.70M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $34.49M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $40.10M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $39.60M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $39.16M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $38.50M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $42.16M 10-K · filed 2024-03-29 | |
| 2022-09-30 | $46.42M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $83.64M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $84.10M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $85.20M 10-K · filed 2023-03-03 | |
| 2021-09-30 | $105.15M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $105.12M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $100.05M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $99.39M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $99.52M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $99.63M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $99.74M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $99.86M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $99.96M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $100.05M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $100.05M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $98.98M 10-K · filed 2020-02-12 | |
| 2018-09-30 | $16.46M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $18.10M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $19.75M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $11.99M 10-K · filed 2019-03-12 | $12.00M 10-K · filed 2018-04-02 |
| 2017-09-30 | $13.64M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $9.77M 10-Q · filed 2017-08-31 | |
| 2016-12-31 | $10.15M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |